— Know what they know.
Not Investment Advice

PCYN OTC

Procyon Corporation
1W: +3.9% 1M: +8.0% 3M: +34.3% YTD: +123.1% 1Y: +145.4% 3Y: +12.5% 5Y: -61.4%
$0.27
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 59 · $2.2M mcap · 3M float · 0.199% daily turnover · Short 90% of daily vol

Cash Flow Trends

Operating Cash Flow
-$441K -619.7% ▼
Capital Expenditures
$55K +14.7% ▲
5Y CAGR: +18.8%
Free Cash Flow
-$495K -295.8% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$245K -96.1% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$768K-$210K-$50K-$341K$34K
Depreciation & Amort.$164K$214K$232K$271K$274K
Stock-Based Comp.$20K$0$0$0$0
Change in Working Capital-$228K-$212K-$12K$28K-$741K
Other Non-Cash Items-$653K$35K-$41K$20K-$32K
Operating Cash Flow$280K-$229K$145K-$61K-$441K
— Investing Activities —
Capital Expenditures-$65K-$83K-$180K-$64K-$54K
Acquisitions (Net)$670K$0$274K$0$0
Investment Purchases-$125K$0-$400K$0$0
Investment Sales-$545K$0$126K$0$250K
Other Investing$545K$0-$274K$0$0
Investing Cash Flow$480K-$83K-$455K-$64K$195K
— Financing Activities —
Net Debt Issuance-$199K-$154K$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$0$0
Financing Cash Flow-$199K-$154K$0$0$0
Net Change in Cash$561K-$466K-$309K-$125K-$245K
Cash End of Period$1M$760K$451K$326K$81K
Free Cash Flow$214K-$312K-$35K-$125K-$495K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms